Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Nov
8
2023
 Rocky Top Update – A Summary of the Tennessee Medical Cannabis Commission’s October Meeting Bradley Arant Boult Cummings LLP
Nov
8
2023
 Ohio Passes Recreational Marijuana Law: What Employers Should Know Jackson Lewis P.C.
Nov
8
2023
 Plaintiff Asks Court to Revive Coors Light False Ad Suit Keller and Heckman LLP
Nov
7
2023
 Massachusetts: Proceed With Caution - New Vaccination Criteria for Hospitals and Other Licensed Health Facilities Foley & Lardner LLP
Nov
7
2023
 FDA Updates CFSAN Online Submission Module (COSM) Keller and Heckman LLP
Nov
6
2023
 USPTO Report On COVID-19 Diagnostic Patent Filings Foley & Lardner LLP
Nov
6
2023
 California’s New Employment Laws for 2024: A Roundup of New Laws Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Nov
6
2023
 2023 National Youth Tobacco Survey Shows Significant Decline in High School Vaping Keller and Heckman LLP
Nov
6
2023
 Second Circuit Reverses Dismissal of “Reef Friendly” Claims Keller and Heckman LLP
Nov
4
2023
 Privacy Tip #378 – Bad Actors Selling Data of 23andMe Users of Ashkenazi Jewish and Chinese Descent Robinson & Cole LLP
Nov
4
2023
 Hair Products with Formaldehyde Are Going Out of Style: Is Your Organization Ready for the Change? Sheppard, Mullin, Richter & Hampton LLP
Nov
3
2023
 Proposed Amendments to Prop 65’s Warning Requirements Keller and Heckman LLP
Nov
3
2023
 FDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule Epstein Becker & Green, P.C.
Nov
3
2023
 Medical Marketer Convicted of $55 Million Fraud Scheme ArentFox Schiff LLP
Nov
2
2023
 FDA Proposes Rule to Prohibit Brominated Vegetable Oil in Food Keller and Heckman LLP
Nov
2
2023
 Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Nov
1
2023
 PFAS in Consumer Products: CPSC Requests Input Keller and Heckman LLP
Nov
1
2023
 FDA Issued a Proposed Rule to Amend Prior Notice Regulation Keller and Heckman LLP
Nov
1
2023
 PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Oct
31
2023
 FDA Seeks Comments on Revised Draft Guidance for Communicating Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Keller and Heckman LLP
Oct
31
2023
 The Haunting in the Cornfield: Relators’ Qui Tam Claim Confirmed Dead by the Eighth Circuit Bradley Arant Boult Cummings LLP
Oct
31
2023
 This is the End: Alabama Medical Cannabis Commission Sets End Game Scenario – Will it Work? Bradley Arant Boult Cummings LLP
Oct
31
2023
 FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products Foley & Lardner LLP
Oct
30
2023
 Alcohol Industry M&A: Common Pitfalls for Founders (and Avoiding Them) Part One: Formulas and Processes McDermott Will & Emery
Oct
30
2023
 District Courts Apply Ninth Circuit Precedent to Dismiss Deceptive Labelling Claims Foley & Lardner LLP
Oct
30
2023
 Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules Mintz
Oct
30
2023
 High Protections on Information Relating to Employees’ Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
 Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies ArentFox Schiff LLP
Displaying 1233 - 1260 of 11744
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins